FDA Inspection
Centrix, Inc.Centrix, Inc. – FDA Inspection, Mar 2, 2022
Record Details
This FDA Inspection record concerns Centrix, Inc., with an inspection on March 2, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Centrix, Inc.
- Inspection Date
- March 2, 2022
- Product Type
- Drugs
View Company Profile
ID · 6ab4d47b-2e29-4fcc-9434-454540864b26
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1163529
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
6- 21 CFR 211.82(a)Examination on receipt, before acceptance
- 21 CFR 211.25(a)Training--operations, GMPs, written procedures
- 21 CFR 211.125(a)Strict control not exercised over labeling issued
- 21 CFR 211.166(a)Lack of written stability program
- 21 CFR 211.67(b)Written procedures not established/followed
- 21 CFR 211.100(b)SOPs not followed / documented
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Centrix, Inc.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| January 31, 2017 | VAI | Center for Drug Evaluation and Research | Unapproved and Misbranded Drugs |
| June 27, 2013 | NAI | Center for Devices and Radiological Health | Compliance: Devices |
| September 24, 2010 | NAI | Center for Devices and Radiological Health | Compliance: Devices |
Other documents for Centrix, Inc.
- FDA Inspection 1000207 - 2017-01-31
- FDA Inspection 839521 - 2013-06-27
- FDA Inspection 681956 - 2010-09-24
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.